The two leading-edge life science clusters BioRN and Ci3 have joint forces to foster knowledge exchange in cancer immunotherapy. Experts in the fields of therapeutic vaccination, cellular and combination therapy, immunomodulation etc. presented their latest findings and new concepts for cancer treatment.

Beneath keynotes and talks of experts from both clusters, the program was complemented by a poster exhibit and numerous opportunities to network and initiate joint projects. On the occasion of its 350th anniversary, Merck hosted the conference.